RxDoctor Payments Data

William Hughes, MD

Surgery · Philadelphia, PANPI 1447206867

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.8%), consulting fees and education — rather than concentrated in one kind of arrangement. Integra Lifesciences Corporation accounts for 77.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $3,219, more than ten times the $238 reported in 2019.

$5,815in general payments, 2019–2025

Across 53 payments — averaging $109.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$5K
  • Avita Medical Americas, LLC$470
  • Polynovo North America LLC$302
  • Vericel Corporation$254
  • Zimmer Biomet$139
  • Urgo Medical North America, LLC$132
$5,250in research payments, 2019–2025

Across 2 payments — averaging $2625.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Avita Medical Americas, LLC$5K

What the payments were for

  • Consulting fees$2,50043%
  • Food & beverage$3,30157%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,815 in reported general payments places this provider in the 80th percentile of 1,424 surgery providers in Pennsylvania.

See all surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$69,885
Medicare patients
154
Services billed
609

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl15$38

Paid to pharmacies, not to this prescriber.

Other surgery in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →